This illustration highlights various antibody structures floating against a blue background, emphasizing their role in the immune response and molecular biology.
getty
A newly developed antibody-based tool exploits the complex “lock-and-key” process many viruses use to infect cells and evade immune detection. In this case, the approach is designed to combat one of the world’s deadliest viruses, Marburg virus, but the same strategy could be adapted to other difficult viruses such as HIV and Chikungunya. Rather than targeting one step of infection, the antibody interferes with multiple stages at once, offering a new way to stop viruses.
This tool works as a single antibody with two distinct functions. One part blocks the virus from attaching to the cell, like preventing a key from entering a lock. If attachment does occur, the virus changes shape to complete entry, effectively “turning the key.” The same antibody then targets the newly exposed structures, closing the brief window viruses rely on to infect cells.
Marburg virus belongs to the same family as Ebola and causes a similar severe bleeding illness, but with even higher fatality rates in many outbreaks. Despite its severity, no approved vaccines or treatments currently exist, in part because the virus’ entry mechanism was poorly understood. This study shows that Marburg virus uses the same lock-and-key entry system and that an engineered antibody can mimic the cell’s receptor and block infection, turning the virus’s own entry mechanism into a vulnerability.
Marburg virus infects cells using a protein on its surface that acts like a molecular key. This protein first attaches to the outside of a cell. Once inside, it changes shape to expose a hidden region that binds an internal receptor, triggering fusion with the cell.
This multi-step process makes the virus difficult to stop. Many vulnerable regions are hidden until the last moment, giving antibodies only a brief window to act. Marburg virus is especially effective at this process, as its surface protein binds more tightly to the internal receptor than similar viruses. This stronger and more stable attachment likely helps explain why the virus enters cells so efficiently.
Notably, a small engineered antibody fragment can block infection by imitating the cell’s own receptor. Instead of attaching randomly to the virus, this molecule binds exactly where the cell receptor would bind, preventing the virus from completing the entry process.
By fitting into the same pocket on the viral protein, the antibody fragment effectively tricks the virus into binding the wrong molecule. Because the binding is extremely tight, it blocks the natural receptor and stops infection.
Like Marburg virus, many viruses rely on similar “lock-and-key” entry mechanisms, where hidden regions are revealed only at the moment of infection. A molecule that mimics the key step in this process could potentially block a wide range of viruses, that depend on shape changes to infect cells.
In addition, the findings help explain why Marburg virus is so dangerous. Its ability to bind tighter, change shape faster, and enter cells more efficiently all contribute to its severity. Understanding these features provides a clearer picture of how the virus causes disease—and how it might be stopped.
As outbreaks of Marburg virus continue, the need for effective treatments remains urgent. Understanding how the virus enters cells offers a critical advantage in developing new interventions.
The ability to design molecules that exploit viral weaknesses marks a turning point in antiviral research. Rather than reacting to infection, future therapies may be able to predict and block it at the earliest stages. In that sense, the next generation of antiviral treatments may not just fight viruses—they may outmaneuver them entirely.
This work is part of a series demonstrating how modern antibody strategies can be developed to enhance immune responses, with potential applications across a wide range of diseases and therapeutic areas.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。